Curis, Inc. (CRIS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Curis, Inc. (CRIS) is down 49.4% since the beginning of the year. At $1 per share, CRIS is trading 84.0% below its 52-week high of $3. Investors who bought $1,000 worth of CRIS shares 5 years ago would now be looking at an investment worth $2.

Curis, Inc. (CRIS) has returned -49.35% so far this year and -78.26% over the past 12 months. Over the last ten years, CRIS has returned -44.70% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Aug 1, 2000, CRIS's average daily return is +0.05%, while the average monthly return is +1.28%. At this rate, an investment would double in approximately 4.5 years.

Historically, 44% of months were positive and 56% were negative. The best month was Dec 2020 with a return of +464.8%, while the worst month was Apr 2022 at -61.6%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 10 months.

On a daily basis, CRIS closed higher 44% of trading days. The best single day was Dec 8, 2020 with a return of +354.9%, while the worst single day was Jun 16, 2010 at -48.2%.

Curis, Inc. has an annualized alpha of 4.16%, beta of 0.97, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since August 02, 2000.

• This stock participated in 203.28% of S&P 500 Index downside but only 81.81% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CRIS ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Curis, Inc. (CRIS) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Curis, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Curis, Inc. was 99.98%, occurring on May 19, 2026. The portfolio has not yet recovered.

The current Curis, Inc. drawdown is 99.98%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Curis, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Curis, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.